|
Attention to CAPA Process Worth Effort, FDA Says
Closing a corrective and preventive action (CAPA) and opening a new one after the original action failed its effectiveness check may give the appearance of malfeasance, according to an FDA investigator.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
|
Subscribe
Archives